A New Paradigm: Using PARP Inhibitors to Treat HER2+ Breast Cancer

Grant

Awarded By

Total Award Amount

  • 450000.00

    • Direct Costs

  • 360000.00

    • Sponsor Award Id

  • CCR17483682

    • Contributor

  • Eddy Yang M.D., Ph.D.   Investigator  
  • Edward Acosta Pharm.D.   Investigator  
  • Erica Stringer-Reasor M.D.   Principal Investigator